These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34781868)

  • 1. Update on Myositis Therapy: From Today's Standards to Tomorrow's Possibilities.
    Glaubitz S; Zeng R; Rakocevic G; Schmidt J
    Curr Pharm Des; 2022; 28(11):863-880. PubMed ID: 34781868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Classification and Management of Inflammatory Myopathies.
    Schmidt J
    J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic inflammatory myopathies.
    Lundberg IE; Fujimoto M; Vencovsky J; Aggarwal R; Holmqvist M; Christopher-Stine L; Mammen AL; Miller FW
    Nat Rev Dis Primers; 2021 Dec; 7(1):86. PubMed ID: 34857798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
    Dalakas MC
    J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myopathies.
    Amato AA; Greenberg SA
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1615-33. PubMed ID: 24305450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.
    Kamperman RG; van der Kooi AJ; de Visser M; Aronica E; Raaphorst J
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic inflammatory myopathies. A review].
    Acosta I; Matamala JM; Jara P; Pino F; Gallardo A; Verdugo R
    Rev Med Chil; 2019 Mar; 147(3):342-355. PubMed ID: 31344172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory muscle diseases.
    Hilton-Jones D
    Curr Opin Neurol; 2001 Oct; 14(5):591-6. PubMed ID: 11562570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review.
    Talotta R; Porrello I; Restuccia R; Magaudda L
    Clin Rheumatol; 2022 Mar; 41(3):593-615. PubMed ID: 34665346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of primary inflammatory myopathies].
    Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
    Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Neurol Clin; 2014 Aug; 32(3):629-46, vii. PubMed ID: 25037082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features.
    Mantegazza R; Bernasconi P; Confalonieri P; Cornelio F
    J Neurol; 1997 May; 244(5):277-87. PubMed ID: 9178151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.